by Raynovich Rod | Dec 24, 2012 | BIOgraph, Biopharmaceuticals
Outstanding Year for Biotechnology -Average Performance is up 35% YTD Many Rayno Life Science Stocks have outperformed the sector and the ETFs: Albany Molecular Inc. (AMRI), a contract research organization with long term experience in drug discovery, development and...
by Raynovich Rod | Dec 21, 2012 | BIOgraph, Clinical Diagnostics and Tools
End of Year Rally Crushed By Turmoil in Budget Talks Up until late yesterday investors were optimistic about a budget deal with the “Kubuki Theater” Congress. You have heard enough about the fiscal cliff and non-starter proposals to avert the fiscal cliff...
by Raynovich Rod | Dec 3, 2012 | 2018 Rayno Tools and Diagnostics Portfolio, BIOgraph, Clinical Diagnostics and Tools
Rayno Tools and Diagnostics Stocks Continue Rally Tools and Diagnostic stocks have been the laggards in the Rayno Life Sciences Portfolio compared to biopharmaceutical stocks. Selected stocks within the Rayno Portfolio have perked up and we suggest some rebalancing....
